St. Luke’s Health System decides to allow carefully monitored, specific-payer access to its EHR after buy-in from all internal stakeholders
Idaho-based St. Luke’s Health System is allowing payers to access patient records directly through their EHR.
Targeting deteriorating margins to preserve mission delivery
A tips-focused article about maintaining tight margin control to ensure an organization can successfully deliver on its mission statement. Includes lessons learned from a recent HFMA Strategic CFO Council meeting.
Quality is table stakes, but patient financial experience of care is key to future referrals
A high-quality patient financial experience of care is key to a steady stream of referrals.
Compromise on surprise medical bills is coming, congressional staff say
A compromise solution for surprise medical bills is nearing and could include costs for both providers and health plans.
The role of intelligent automation in reducing waste and improving efficiency in the revenue cycle
A portion of the wasteful spending in healthcare can be curbed by automating repetitive tasks.
Not like the others: House Ways and Means surprise bill legislation
Provider friendly House Ways and Means surprise bill draft legislation doesn't rely on a benchmark payment rate like competing versions.
Hard truths about the state of the healthcare industry
HFMA's president and CEO, Joseph Fifer, provides a straightforward assessment of likely changes to come in healthcare in the 2020s and what healthcare executives should do to to prepare.
HFMA conference in New Orleans focuses on achieving a consumer-centric revenue cycle
HFMA conference in New Orleans focuses on achieving a consumer-focused revenue cycle.
Spectrum Health uses certification competition to foster engagement with HFMA
Spectrum Health sponsored a competition among its revenue cycle leaders, with the goal of encouraging their staff members to become HFMA Enterprise members and obtain HFMA certifications.
Health plans expect to offer generic drugs by 2022
A health plan alliance with hospitals aims to produce generic drug alternatives that will save consumers “hundreds of millions” of dollars.